Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Eben Tessari
»
Articles
|
Eben Tessari
27
Followers
1
Following
You are currently following Eben Tessari
Stop Following
You are no longer following Eben Tessari
Profile
Articles (71)
Comments (17)
Sort by:
Latest
|
Editors' Picks
|
Most Commented
|
Most Popular
Biogen to Collaborate on Cancer Treatment
on Mar 25, 2009
•
BIIB
CV Tells Astellas to Take a Hike: Looks to Gilead
on Mar 12, 2009
•
ALPMF.PK
,
CVTX
,
GILD
Pharma: Are Mega Mergers Good for Business?
on Mar 10, 2009
•
DNA
,
LLY
,
MRK
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
on Mar 09, 2009
•
MRK
,
SGP
Vertex to Buy Hepatitis C Drug Developer ViroChem for $375 Million
on Mar 04, 2009
•
VRTX
Astellas Announces Offer to Buy CV Therapeutics
on Mar 02, 2009
•
ALPMF.PK
,
CVTX
Lilly Taps NeuroSearch for Preclinical Discovery Deal
on Feb 18, 2009
•
LLY
Idenix and GSK Partner on HIV Treatment Drug
on Feb 06, 2009
•
GSK
,
IDIX
Astellas Proposes to Acquire CV Therapeutics for $1Billion
on Jan 27, 2009
•
ALPMF.PK
5 Reasons Pfizer Shouldn't Buy Wyeth
on Jan 25, 2009
•
PFE
,
WYE
Bristol-Myers Jumps into Hepatitis C Race
on Jan 13, 2009
•
BMY
Cubist and Alnylam, An Odd Partnership
on Jan 11, 2009
•
ALNY
,
CBST
BioMarin Rolls the Dice on a New Lupus Drug
on Jan 08, 2009
•
BMRN
GlaxoSmithKline Allies With Dynavax to Target Autoimmune Diseases
on Dec 17, 2008
•
DVAX
,
GSK
Ascent Enters $200M Pact With Novartis
on Dec 09, 2008
•
NVS
Can MicroRNA Reverse Heart Disease?
on Dec 01, 2008
•
ALNY
,
ISIS
JNJ / Omrix: Potential Synergies
on Nov 24, 2008
•
JNJ
,
OMRI
Bristol-Myers' Collaboration with Exelixis Is Looking Lucrative
on Nov 24, 2008
•
BMY
,
EXEL
BBM Looks for Bargain in YM Biosciences Acquisition Proposal
on Nov 15, 2008
•
YMI
ArQule Joins Forces with Daiichi Sankyo to Fight Cancer
on Nov 11, 2008
•
ARQL
Will TorreyPines Sale of Its Alzheimer Genetics Research Save the Company?
on Nov 11, 2008
•
ESALY.PK
,
TPTX
Onyx's $320M Bet on BTG's Anticancer Compound
on Nov 10, 2008
•
ONXX
Osiris Leaps on $1.38 Billion Genzyme Stem-Cell Deal
on Nov 05, 2008
•
GENZ
EMD Serono Snags US license for Tesamorelin From Theratechnologies
on Oct 31, 2008
•
MKGAY.PK
GlaxoSmithKline to Acquire Genelabs Technologies For $57M
on Oct 31, 2008
•
GNLB
,
GSK
Glaxo and AFFiRiS Sign Alzheimer’s Disease Vaccine Deal
on Oct 30, 2008
•
GSK
Neuroptix Raises $18.5 Million in Successful B Round
on Oct 22, 2008
Archer Pharmaceuticals: New Company to Target Alzheimer’s Disease
on Oct 22, 2008
Apitope Raises EUR 10 Million in Series A Financing
on Oct 22, 2008
Gilead Turns in Sweet Earnings Numbers
on Oct 19, 2008
•
GILD
ImClone to Reveal Mystery Suitor?
on Sep 29, 2008
•
IMCL
,
LLY
,
PFE
GSK and Cellzome in Kinase Technology Alliance
on Sep 10, 2008
•
GSK
1
2
3
Next Page
Articles by Ticker
ABMD
,
ACOR
,
AGN
,
ALNY
,
ALPMF.PK
,
ALTH
,
ARQL
,
AZN
,
BIIB
,
BMRN
,
BMS
,
BMY
,
CBST
,
CVTX
,
DNA
,
DVAX
,
ELN
,
ELXR
,
ENZN
,
ESALY.PK
,
EXEL
,
GENZ
,
GILD
,
GNLB
,
GSK
,
IDIX
,
IMCL
,
ISIS
,
JAZZ
,
JNJ
,
KOSN
,
LGND
,
LLY
,
MKGAY.PK
,
MRK
,
NVS
,
OMRI
,
ONXX
,
PDLI
,
PFE
,
RHHBY.PK
,
SCMP
,
SGP
,
SHPGY
,
SNY
,
SOMX
,
TEVA
,
TKPHF.PK
,
TPTX
,
TRCA
,
VNLS
,
VRTX
,
WYE
,
YMI
Latest Comments on Eben Tessari's Articles
User 400998
on
MS Drug Fampridine Sends Acorda Stock Way Up
: DOES ANYONE KNOW WHEN IT WILL BE AVAILABLE TO ALL OF US? IS IT...
more »
RamblinRose
on
Ascent Enters $200M Pact With Novartis
: well, there is more to pepducins than marketing; they do have the...
more »
Edward, Lord Clarendon
on
Pharma: Are Mega Mergers Good for Business?
: PLENTY OF MONEY TO BE MADE IN MERGERS!! It's easy. Lie,...
more »
raytayzmd
on
Pharma: Are Mega Mergers Good for Business?
: ...oh, probably great for business but when your health insurance...
more »
donzelion
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: From a mergers perspective, a 44% cash, 56% stock deal seems...
more »
Moon Kil Woong
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: I think this shows someone made a quick buck a week ago before the...
more »
Thefigman
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: I think this transaction shows that Merck's pipeline might not be...
more »
Michael L
on
Merck to Buy Schering-Plough in $41.1 Billion Cash and Stock Deal
: It seems Merck never runs out of ways to disappoint its investors.
more »
donzelion
on
Astellas Proposes to Acquire CV Therapeutics for $1Billion
: I'm fairly ignorant about pharms (which is why I'm buying a...
more »
User 345757
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: Why would PFE wanna move into the low-margin biz of generics?
more »
Guero
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: You make a great point. Spot on. It is what it is. They are...
more »
Crocodilian
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: While outsiders often look at drug development as the raison...
more »
sorsorday
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: You can say the same thing for all business transaction. In...
more »
Guero
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: Pfizer pfires 800 R&D scientists even though they have no patent...
more »
Chris B
on
5 Reasons Pfizer Shouldn't Buy Wyeth
: The evidence is in: around 70% of mergers actually destroy...
more »
Latest Comments on Eben Tessari's Articles
Latest Comments on Eben Tessari's Articles